Israeli Missile Interceptors Have Dwindled to “Double Digits”: Trump Administration Official

Key Takeaways

• Israel's interceptor stock fell to under 100 units, double-digit range.
• 122 Arrow and 22 THAAD missiles used by March 24.
• Each Arrow costs $2‑3 million; THAAD $12 million, production takes months.
• Iran fires missiles to drain Israel's interceptors, prompting US aid.
• US Aegis missiles fired 431 times, stretching its own deterrent stockpile.

Pulse Analysis

The rapid depletion of Israel’s missile‑defense arsenal reflects both the intensity of the current conflict and the high cost of modern interceptors. By the end of March, Israel had used more than 80% of its Arrow missiles and nearly half of its THAAD inventory, a loss that cannot be quickly remedied given the $2‑3 million price tag per Arrow and the $12 million cost of each THAAD. Production lines, even with Lockheed Martin’s plan to boost output to 400 units annually, require years to reach full capacity, leaving a critical gap in Israel’s ability to absorb sustained missile barrages.

Iran’s strategy appears to exploit this vulnerability, launching older, less accurate rockets to consume Israeli interceptors while reserving advanced warheads for later phases. The tactic forces Israel to be selective, often allowing less threatening missiles to fall in open areas, and compels the United States to step in with Aegis‑equipped destroyers. The U.S. has already expended 431 of its 2,500 naval interceptors, a figure that strains its own stockpiles earmarked for deterrence against China and for protecting Gulf allies. This dual‑theater demand highlights a broader supply‑chain bottleneck in high‑cost missile‑defense munitions.

Looking ahead, Israel’s announced acceleration of Arrow production may shore up its defenses, but the timeline remains measured in years, not weeks. Meanwhile, the Pentagon’s modest procurement of 12 THAAD units in 2025 and a projected 37 this year does little to alleviate immediate shortfalls. For defense contractors, the situation underscores a lucrative yet urgent market for rapid‑production interceptor technologies, while policymakers must weigh the trade‑offs between regional commitments and global deterrence postures. The evolving interceptor scarcity could reshape strategic calculations across the Middle East and beyond.